New diabetes clinical trial: Pemafibrate for Symptomatic ICAS RCT

Published on: 2026-05-01T04:00:00Z
Conditions: Intracranial Atherosclerotic Disease (ICAD); Hypertriglyceridaemia; Stroke (CVA) or TIA
Interventions: Drug: Pemafibrate
Sponsors: Tokyo Women's Medical University; Kowa Company, Ltd.
Not yet recruiting
https://ift.tt/MSu1dWl